Description: This track will focus on critical reagents and method validation of PK and Immunogenicity assays for support of drug development.
We will discuss strategies for the latest and greatest drugs followed by case studies including generating critical reagents and method validation of PK and ADA assays.
The drugs that we will discuss are Oligos, ADCs, ARCs, and Bi-Specific/Fusion proteins
CROs have the advantage of being exposed to the latest and greatest drugs. The goal of this talk is to share our tips and tricks.
Learning Objectives:
Critical reagents for support of Oligo's, ADCs, ARCs, and bi-specifics/fusion proteins.
A check list for PK assays for support of Oligo's, ADCs, ARCs, and bi-specifics/fusion proteins.
A check list for ADA assays for support of Oligo's, ADCs, ARCs, and bi-specifics/fusion proteins.
